Article

The Importance of Clinical Trials in Multiple Myeloma

As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.

The list of available treatment options for multiple myeloma has grown in the past decade, However, as patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.

In an interview with OncLive®, CURE®’s sister publication, Mailankody explained how investigational drugs can play a role in the treatment of patients with myeloma as they advance past the initial lines of treatment.

Transcription:

I think with all these different treatment options, particularly in the relapsed/refractory setting, referring patients when appropriate to clinical trials of these novel treatments — for instance, the CAR-T cells and bispecific antibodies and others that are coming along that are not currently available as standard treatments but might provide significant clinical benefit for patients in the context of clinical trials — would be something else I think people should keep in mind as they see patients through their treatment course.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.